Impact Report 2022
The difference we made in 2022
Search results
The difference we made in 2022
Find out more about the difference we made in 2024.
Find out more about the difference we made in 2023, because of you.
You can download the last three years’ Trustees’ Annual Report & Accounts. They are also available on the Charity Commission website.
This edition of Look Forward includes the very latest news about an experimental therapy by Retina UK funded researchers, an article about one of our PhD students, a calendar of events in 2025, the usual research news round-up and lots more. Please take the time to complete our Sight Loss Survey, enclosed with this edition. You can find out more about the Survey.
We carried out our first Sight Loss Survey in 2019 and used what we learned to improve our support. It was repeated in 2022 and in 2025. These are the findings.
Since we were founded in 1976, we have invested more than £18 million into some of the most pioneering medical research - because of amazing supporters like you.
Refsum syndrome is an inherited metabolic condition, associated with elevated phytanic acid plasma levels, which impacts many body systems.
Usher syndrome is an inherited condition that affects both hearing and vision.
Welcome to the winter edition of Look Forward. It’s packed full of news from our Conferences, the latest research news and an interview with Hassina Zeriri, one of our funded PhD students.
We have also included details of lots of ways you can get involved with Retina UK over the coming months, along with some suggested festive fundraising for the Christmas period.